Andreas Karakatsanis
Överläkare vid Institutionen för kirurgiska vetenskaper; Endokrinkirurgi
- E-post:
- andreas.karakatsanis@uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA - Postadress:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA
- Akademiska meriter:
- MD, PhD
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Urval av publikationer
- Association of a Prophylactic surgical approach to Stage IV Small Intestinal Neuroendocrine Tumors with Survival. (2018)
- Simplifying Logistics and Avoiding the Unnecessary in Patients with Breast Cancer Undergoing Sentinel Node Biopsy. A Prospective Feasibility Trial of the Preoperative Injection of Super Paramagnetic Iron Oxide Nanoparticles (2018)
- Clinical signs of fibrosis in small intestinal neuroendocrine tumours (2017)
- Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer (2017)
- SentiNot (2017)
- Over surgery in breast cancer (2017)
- Midkine Is a New Novel Serum Biomarker in Small Intestinal Neuroendocrine Tumors (SI-NETs) (2016)
- The Nordic SentiMag trial (2016)
- The use of superparamagnetic iron oxide (SPIO) as sole method for the detection of sentinel node (SN) in breast cancer. The MONOS study (2016)
Senaste publikationer
- Magnetically guided surgery after primary systemic therapy for breast cancer (2024)
- Effect of mode of delivery of patient reported outcomes in patients with breast disease (2024)
- Effect of standardised surgical assessment and shared decision-making on morbidity and patient satisfaction after breast conserving therapy (2023)
- Localization Techniques for Non-Palpable Breast Lesions (2023)
- Natural Language Processing to Extract Meaningful Information from a Corpus of Written Knowledge in Breast Cancer (2023)
Alla publikationer
Artiklar
- Magnetically guided surgery after primary systemic therapy for breast cancer (2024)
- Effect of mode of delivery of patient reported outcomes in patients with breast disease (2024)
- Effect of standardised surgical assessment and shared decision-making on morbidity and patient satisfaction after breast conserving therapy (2023)
- Localization Techniques for Non-Palpable Breast Lesions (2023)
- Natural Language Processing to Extract Meaningful Information from a Corpus of Written Knowledge in Breast Cancer (2023)
- Keeping a Breast with Social Media (2023)
- Chest wall perforator flaps for breast reconstruction (2023)
- Comprehending the impact of #Breastcancer, #Breastsurgery and related hashtags on Twitter (2023)
- Outcomes of Different Quality of Life Assessment Modalities After Breast Cancer Therapy (2023)
- Magnetic Seed vs Guidewire Breast Cancer Localization With Magnetic Lymph Node Detection (2023)
- Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer (2023)
- Outcome of different radiotherapy strategies after breast conserving surgery in patients with ductal carcinoma in situ (DCIS) (2023)
- Text mining and word embedding for classification of decision making variables in breast cancer surgery (2022)
- A Comparison of Skin Staining after Sentinel Lymph Node Biopsy in Women Undergoing Breast Cancer Surgery Using Blue Dye and Superparamagnetic Iron Oxide Nanoparticle (SPIO) Tracers (2022)
- Yield of Surveillance Imaging After Mastectomy With or Without Reconstruction for Patients With Prior Breast Cancer (2022)
- ASO Author Reflections (2022)
- ASO Visual Abstract (2022)
- A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence (2022)
- Optimizing Dose and Timing in Magnetic Tracer Techniques for Sentinel Lymph Node Detection in Early Breast Cancers (2021)
- Magnetic-Guided Axillary UltraSound (MagUS) Sentinel Lymph Node Biopsy and Mapping in Patients with Early Breast Cancer. A Phase 2, Single-Arm Prospective Clinical Trial (2021)
- Axillary evaluation in ductal cancer in situ of the breast (2021)
- Mammographic Density Changes over Time and Breast Cancer Risk (2021)
- The prognostic and predictive impact of low estrogen receptor expression in early breast cancer (2021)
- The Impact of the COVID-19 Pandemic on Surgical Management of Breast Cancer (2021)
- Challenging the current norm (2021)
- The challenge of avoiding over- and under-treatment in older women with ductal cancer in situ (2020)
- Not all artifacts after magnetic guided sentinel lymph node biopsy are necessarily related to superparamagnetic iron oxide nanoparticles (2020)
- A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery (2019)
- Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study) (2019)
- The Use of Hydrodissection in Nipple- and Skin-sparing Mastectomy (2019)
- ASO Author Reflections (2019)
- Long-Term Outcome After Retro-Areolar Versus Peri-Tumoral Injection of Superparamagnetic Iron Oxide Nanoparticles (SPIO) for Sentinel Lymph Node Detection in Breast Cancer Surgery. (2019)
- Neoadjuvant chemotherapy for early breast cancer (2018)
- Association of a Prophylactic surgical approach to Stage IV Small Intestinal Neuroendocrine Tumors with Survival. (2018)
- Ex Vivo Activity of Cytotoxic Drugs and Targeted Agents in Small Intestinal Neuroendocrine Tumors (2018)
- Ex vivo activity of cytotoxic drugs and targeted agents in small intestinal neuroendocrine tumors (2018)
- Optimisation of breast MRI compatibility after sentinel node biopsy with paramagnetic tracers (2018)
- Simplifying Logistics and Avoiding the Unnecessary in Patients with Breast Cancer Undergoing Sentinel Node Biopsy. A Prospective Feasibility Trial of the Preoperative Injection of Super Paramagnetic Iron Oxide Nanoparticles (2018)
- Meta-analysis of neoadjuvant therapy and its impact in facilitating breast conservation in operable breast cancer (2018)
- SentiDose - A dose optimizing study with SiennaXP, a superparamagnetic iron oxide for sentinel node detection (2018)
- Multicentre study evaluating the surgical learning curve for posterior retroperitoneoscopic adrenalectomy (2018)
- Abstract P3-01-11: Discoloration after injection of super paramagnetic iron oxide (SPIO) for sentinel node biopsy. A long term qualitative follow-up study (2018)
- Clinical signs of fibrosis in small intestinal neuroendocrine tumours (2017)
- Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer (2017)
- SentiNot (2017)
- Over surgery in breast cancer (2017)
- Midkine Is a New Novel Serum Biomarker in Small Intestinal Neuroendocrine Tumors (SI-NETs) (2016)
- The Nordic SentiMag trial (2016)
- The use of superparamagnetic iron oxide (SPIO) as sole method for the detection of sentinel node (SN) in breast cancer. The MONOS study (2016)
- Ex vivo activity of cytotoxic drugs and targeted agents in Small Intestinal NETs
- A novel technique to avoid sentinel node biopsy in patients with a preoperative diagnosis of ductal cancer in situ and its implementations on current practice.
Böcker
